Zentalis Pharmaceuticals, Inc. (ZNTL) EBITDA Margin (2024)
Zentalis Pharmaceuticals (ZNTL) recorded EBITDA Margin of -184.33% in Q4 2024.
Powered by 
Analysis
Zentalis Pharmaceuticals, Inc. (ZNTL) EBITDA Margin (2024) Analysis & Trends
For FY2024, Zentalis Pharmaceuticals reported EBITDA Margin of -281.64%.
Peer Set
Peer Comparison
API Access
Zentalis Pharmaceuticals, Inc. EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZNTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ZNTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZNTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();